Reliability of Glomerular Filtration Rate Estimated by Creatinine-Based Formulas in Moderate to Severe Proteinuria.

IF 8.5 1区 医学 Q1 UROLOGY & NEPHROLOGY Clinical Journal of the American Society of Nephrology Pub Date : 2024-10-24 DOI:10.2215/cjn.0000000602
Carmine Zoccali,Fabio Pasquale Provenzano,Giovanni Tripepi,Fabiola Carrara,Francesca Mallamaci,Annalisa Perna,Pierre Delanaye,Pietro Ruggenenti,Giuseppe Remuzzi
{"title":"Reliability of Glomerular Filtration Rate Estimated by Creatinine-Based Formulas in Moderate to Severe Proteinuria.","authors":"Carmine Zoccali,Fabio Pasquale Provenzano,Giovanni Tripepi,Fabiola Carrara,Francesca Mallamaci,Annalisa Perna,Pierre Delanaye,Pietro Ruggenenti,Giuseppe Remuzzi","doi":"10.2215/cjn.0000000602","DOIUrl":null,"url":null,"abstract":"BACKGROUND\r\nCreatinine-based Glomerular Filtration rate (GFR) formulas introduce a substantial bias in GFR estimations in patients with frank nephrotic syndrome. The bias and accuracy of creatinine-based GFR estimates (eGFR) in patients with non-nephrotic proteinuria need better characterization.\r\n\r\nMETHODS\r\nWe utilized data from the Ramipril in non-diabetic renal failure (REIN 1) and REIN 2 trials involving non-diabetic chronic kidney disease (CKD) patients with proteinuria to compare eGFRs derived from the CKD Epidemiology Consortium (CKD-EPI)formulas (with and without race), and the European Kidney Function Consortium (EKFC) equations with iohexol clearance (a gold-standard GFR measure, measured glomerular filtration rate [mGFR]). Bias was defined as the median difference between eGFR and mGFR, while accuracy was assessed using P30 and P15 metrics, which represent the percentage of eGFR values within ±30% and ±15% of mGFR, respectively.\r\n\r\nRESULTS\r\nThe median bias of the three formulas being compared did not differ, being minimal and in a strict range (0.04 to 0.05 ml/ml/min/1.73m2) in the REIN 1 study and (-0.04 to -0.03 ml/min/1.73 m2) in the REIN 2 study. These findings were confirmed in analyses stratified by age and mGFR. The global accuracy of the three formulas regarding P30% showed sufficient accuracy (P30 >75%) in REIN 1 and all strata in REIN 2, but the mGFR stratum <15 ml/min/1.73m2.\r\n\r\nCONCLUSION\r\nThe CKD-EPI (with and without race), and EKFC equations show no significant bias and sufficient accuracy in patients with proteinuria. These formulas can be safely applied to non-diabetic CKD patients with moderate to severe proteinuria.","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":null,"pages":null},"PeriodicalIF":8.5000,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Journal of the American Society of Nephrology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2215/cjn.0000000602","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

BACKGROUND Creatinine-based Glomerular Filtration rate (GFR) formulas introduce a substantial bias in GFR estimations in patients with frank nephrotic syndrome. The bias and accuracy of creatinine-based GFR estimates (eGFR) in patients with non-nephrotic proteinuria need better characterization. METHODS We utilized data from the Ramipril in non-diabetic renal failure (REIN 1) and REIN 2 trials involving non-diabetic chronic kidney disease (CKD) patients with proteinuria to compare eGFRs derived from the CKD Epidemiology Consortium (CKD-EPI)formulas (with and without race), and the European Kidney Function Consortium (EKFC) equations with iohexol clearance (a gold-standard GFR measure, measured glomerular filtration rate [mGFR]). Bias was defined as the median difference between eGFR and mGFR, while accuracy was assessed using P30 and P15 metrics, which represent the percentage of eGFR values within ±30% and ±15% of mGFR, respectively. RESULTS The median bias of the three formulas being compared did not differ, being minimal and in a strict range (0.04 to 0.05 ml/ml/min/1.73m2) in the REIN 1 study and (-0.04 to -0.03 ml/min/1.73 m2) in the REIN 2 study. These findings were confirmed in analyses stratified by age and mGFR. The global accuracy of the three formulas regarding P30% showed sufficient accuracy (P30 >75%) in REIN 1 and all strata in REIN 2, but the mGFR stratum <15 ml/min/1.73m2. CONCLUSION The CKD-EPI (with and without race), and EKFC equations show no significant bias and sufficient accuracy in patients with proteinuria. These formulas can be safely applied to non-diabetic CKD patients with moderate to severe proteinuria.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
中度至重度蛋白尿患者以肌酐为基础的公式估算的肾小球滤过率的可靠性。
背景基于肌酐的肾小球滤过率(GFR)计算公式会对肾病综合征患者的肾小球滤过率估算产生很大偏差。非肾病性蛋白尿患者基于肌酐的肾小球滤过率估算(eGFR)的偏差和准确性需要更好的鉴定。方法:我们利用雷米普利治疗非糖尿病肾衰竭(REIN 1)和 REIN 2 试验的数据(涉及蛋白尿的非糖尿病慢性肾病 (CKD) 患者),比较了由 CKD 流行病学联盟 (CKD-EPI) 公式(含种族和不含种族)和欧洲肾功能联盟 (EKFC) 公式得出的 eGFR 与碘海醇清除率(黄金标准 GFR 测量方法,即测定的肾小球滤过率 [mGFR])。偏差被定义为 eGFR 与 mGFR 之间的中位数差异,而准确性则使用 P30 和 P15 指标进行评估,这两个指标分别代表 eGFR 值在 mGFR ±30% 和 ±15% 范围内的百分比。结果比较的三种公式的中位数偏差没有差异,在 REIN 1 研究中偏差最小且范围严格(0.04 至 0.05 ml/ml/min/1.73m2),在 REIN 2 研究中偏差最小且范围严格(-0.04 至 -0.03 ml/min/1.73 m2)。这些结果在按年龄和 mGFR 进行的分层分析中得到了证实。在 REIN 1 和 REIN 2 的所有分层中,这三个公式关于 P30% 的总体准确性显示出足够的准确性(P30 >75%),但 mGFR 分层 <15 ml/min/1.73 m2。这些公式可安全地应用于中度至重度蛋白尿的非糖尿病 CKD 患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
12.20
自引率
3.10%
发文量
514
审稿时长
3-6 weeks
期刊介绍: The Clinical Journal of the American Society of Nephrology strives to establish itself as the foremost authority in communicating and influencing advances in clinical nephrology by (1) swiftly and effectively disseminating pivotal developments in clinical and translational research in nephrology, encompassing innovations in research methods and care delivery; (2) providing context for these advances in relation to future research directions and patient care; and (3) becoming a key voice on issues with potential implications for the clinical practice of nephrology, particularly within the United States. Original manuscript topics cover a range of areas, including Acid/Base and Electrolyte Disorders, Acute Kidney Injury and ICU Nephrology, Chronic Kidney Disease, Clinical Nephrology, Cystic Kidney Disease, Diabetes and the Kidney, Genetics, Geriatric and Palliative Nephrology, Glomerular and Tubulointerstitial Diseases, Hypertension, Maintenance Dialysis, Mineral Metabolism, Nephrolithiasis, and Transplantation.
期刊最新文献
Bisphosphonate Use After Kidney Transplantation Is Associated with Lower Fracture Risk. Surrogate Endpoints in APOL1-Associated Kidney Disease: Evaluation in Three Cohorts. From Home to Wearable Hemodialysis: Barriers, Progress, and Opportunities. Potential Role of Mineralocorticoid Receptor Antagonists in Nondiabetic Chronic Kidney Disease and Glomerular Disease. Exercise and Cognitive Function in Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Efficacy and Harms.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1